Biggest News Aggregation in the World
📰 Nasdaq Prtk News

Page 2 - Nasdaq Prtk News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Prtk. Real-time updates on events, politics, business and more.

Paratek Pharmaceuticals (NASDAQ:PRTK) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. A number of other equities analysts have also recently weighed in on the stock. HC Wainwright cut shares of Paratek Pharmaceuticals from […]
Institutional Investors Weigh In On Paratek Pharmaceuticals Capital Management Paratek Pharmaceuticals Stock Performance Blackrock Inc News Ratings For Paratek Pharmaceuticals Daily Paratek Pharmaceuticals Inc

HC Wainwright Downgrades Paratek Pharmaceuticals (NASDAQ:PRTK) to Neutral

HC Wainwright lowered shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a neutral rating in a research note released on Wednesday morning, The Fly reports. Several other equities analysts have also recently commented on the stock. BTIG Research decreased their price target on shares of Paratek Pharmaceuticals from $24.00 to […]
Jamesd Dondero Cm Management Institutional Investors Weigh In On Paratek Pharmaceuticals News Ratings For Paratek Pharmaceuticals Daily Paratek Pharmaceuticals Paratek Pharmaceuticals Trading Down

Paratek Pharmaceuticals (NASDAQ:PRTK) Upgraded at StockNews.com

StockNews.com upgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a hold rating to a buy rating in a report issued on Tuesday. A number of other research firms have also weighed in on PRTK. BTIG Research cut their price objective on shares of Paratek Pharmaceuticals from $24.00 to $5.00 in a research note […]
Jamesd Dondero Hedge Funds Weigh In On Paratek Pharmaceuticals News Ratings For Paratek Pharmaceuticals Daily Paratek Pharmaceuticals Company Profile Commonwealth Equity Services Paratek Pharmaceuticals Inc

Paratek Pharmaceuticals (NASDAQ:PRTK) Rating Lowered to Neutral at HC Wainwright

Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) was downgraded by HC Wainwright from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, The Fly reports. Several other research analysts have also weighed in on PRTK. StockNews.com raised Paratek Pharmaceuticals from a “hold” rating to a “buy” rating in a research […]
Jamesd Dondero Securities Exchange Commission News Ratings For Paratek Pharmaceuticals Daily Paratek Pharmaceuticals Company Profile Paratek Pharmaceuticals Inc Cutter Co Brokerage Inc

Paratek Pharmaceuticals (NASDAQ:PRTK) Downgraded by HC Wainwright to "Neutral"

HC Wainwright downgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a neutral rating in a report issued on Wednesday, The Fly reports. Several other research firms also recently commented on PRTK. Jefferies Financial Group downgraded shares of Paratek Pharmaceuticals from a buy rating to a hold rating in a […]
Jamesd Dondero Paratek Pharmaceuticals Institutional Trading Of Paratek Pharmaceuticals Vanguard Group Inc Paratek Pharmaceuticals Price Performance Topco Ltd

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Paratek Pharmaceuticals (NASDAQ:PRTK) Lifted to Buy at StockNews.com

Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday. Several other equities research analysts have also recently issued reports on PRTK. BTIG Research cut their target price on Paratek Pharmaceuticals from $24.00 to $5.00 in a research note […]
Jamesd Dondero Paratek Pharmaceuticals Cutter Co Brokerage Inc News Ratings For Paratek Pharmaceuticals Daily Paratek Pharmaceuticals Inc Paratek Pharmaceuticals Price Performance

Paratek Pharmaceuticals (NASDAQ:PRTK) Downgraded by StockNews.com

StockNews.com downgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a hold rating in a report issued on Saturday. Other equities research analysts have also recently issued reports about the company. HC Wainwright lowered their target price on Paratek Pharmaceuticals from $10.00 to $6.00 in a research note on Wednesday, […]
Jamesd Dondero Carlyle Group Inc News Ratings For Paratek Pharmaceuticals Daily Kathmere Capital Management Cm Management Paratek Pharmaceuticals Trading Down

Paratek Pharmaceuticals (NASDAQ:PRTK) Downgraded by StockNews.com to Hold

StockNews.com lowered shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Saturday. Several other equities research analysts also recently commented on PRTK. BTIG Research decreased their price objective on Paratek Pharmaceuticals from $24.00 to $5.00 in a report on Tuesday, […]
Jamesd Dondero Capital Management Carlyle Group Inc Paratek Pharmaceuticals Inc News Ratings For Paratek Pharmaceuticals Daily Blackrock Inc
Source: wkrb13.com

Paratek Pharmaceuticals (NASDAQ:PRTK) Price Target Lowered to $6.00 at HC Wainwright

Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) had its price objective cut by HC Wainwright from $10.00 to $6.00 in a research note published on Wednesday, The Fly reports. HC Wainwright also issued estimates for Paratek Pharmaceuticals’ Q2 2023 earnings at ($0.30) EPS, Q3 2023 earnings at ($0.24) EPS, Q4 2023 earnings at ($0.19) EPS, FY2023 […]
United States Jamesd Dondero Capital Management News Ratings For Paratek Pharmaceuticals Daily Paratek Pharmaceuticals Inc Paratek Pharmaceuticals

Paratek Pharmaceuticals (NASDAQ:PRTK) Upgraded by StockNews.com to "Buy"

Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. A number of other equities research analysts have also recently commented on PRTK. HC Wainwright dropped their price objective on shares of Paratek […]
Jamesd Dondero Cm Management Paratek Pharmaceuticals Inc Paratek Pharmaceuticals Trading Paratek Pharmaceuticals Company Profile Arete Wealth Advisors

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science